Etihad Cargo has reported a 50 per cent year-on-year rise in pharma shipments under its specialized PharmaLife product.
The double-digit annual growth comes as the carrier marks its second anniversary of achieving and operating IATA CEIV certification for pharmaceutical and life science logistics.
Etihad Cargo currently operates across more than 1,050 IATA CEIV Pharma/GDP certified trade lands which ensure the integrity of products during transportation.
"Etihad Cargo has substantial expertise in the global transportation of temperature controlled and time-sensitive pharmaceutical products, including vaccines, operating to stringent manufacturers' requirements," explained Martin Drew, Senior Vice President Sales and Cargo, Etihad Aviation Group. "The IATA CEIV certification has reaffirmed the carrier’s strength in this sector and strengthened partner trust to deliver a quality product solution across 54 pharma stations with dedicated experts available for advice."
The launch of the Abu Dhabi-based Hope Consortium towards the end of 2020 has contributed to the end of year increase and is expected to support Etihad Cargo’s pharmaceutical shipment growth through 2021.
A member of IATA’s Time and Temperature Working Group, Etihad Cargo is planning to boost its global pharma sector credentials through an ongoing education programme which has already reached a worldwide audience of over 600 professionals through 30 webinars.